Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis | |
Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng | |
刊名 | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
2019 | |
卷号 | 24期号:9 |
关键词 | Soluble interleukin-2 receptor Hemodialysis Malignancy event Malignancy-related mortality |
ISSN号 | 1341-9625 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3597061 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chen XiaoHong,Shen Bo,Xiang FangFang,et al. Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY,2019,24(9). |
APA | Chen XiaoHong.,Shen Bo.,Xiang FangFang.,Guo Man.,Zou JianZhou.,...&Zhang Boheng.(2019).Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY,24(9). |
MLA | Chen XiaoHong,et al."Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis".INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 24.9(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论